Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019. The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited' in July, 2021 and to Aarti Pharmalabs Limited in 2022. Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc.
In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Re ...gulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.
In 2021-22, the Pharmaceutical Division was demerged from Aarti Industries Limited into its wholly owned subsidiary, Aarti Pharmalabs Limited, via Scheme of Arrangement for Demerger, thus making it effective on October 17, 2022 and operational from July 1, 2021. Thereafter, Company commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.
The R&D centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company commenced operations for its semi-commercial block at the USFDA intermediate manufacturing site in Vapi in FY24. The Xanthine capacity enhanced to 5000 TPA in 2024.
Similar Stocks
Company
52 Week
Market Price
P/E Ratio
FAQs on Aarti Pharmalabs Ltd
1. Can I buy Aarti Pharmalabs Ltd from PL Capital? ›
Yes, you can invest in Aarti Pharmalabs Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Aarti Pharmalabs Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Aarti Pharmalabs Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Aarti Pharmalabs Ltd pay dividends? ›
Aarti Pharmalabs Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Aarti Pharmalabs Ltd ? ›
As of
23-09-2025 the share price for Aarti Pharmalabs Ltd. is 871.65 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Aarti Pharmalabs Ltd ? ›
The 52-week high and low of Aarti Pharmalabs Ltd share price is ₹ 557.05 - ₹ 971 as of
23-09-2025 .
PL Ringside View
Our fireside chat series where industry experts and top management share valuable insights for our clients
